For NANOG and ALDH1 inhibitors, such as Amcasertib and Disulfiram 48, 49, our preliminary data showed that their anti-tumor effect in HNSCC was not as good as MYCi975. This evidence concerns the gene NANOG and head and neck squamous cell carcinoma.